Semax BDNF and NGF research has produced one of the more substantial bodies of preclinical literature on synthetic neuropeptide modulation of neurotrophic factors. Brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) are two of the most studied neurotrophic proteins in the central nervous system, and Semax has been characterized in multiple research models for its effects on the expression and function of both factors. As the neurotrophic factor research component of the Semax research cluster, this article reviews the published literature on Semax effects on BDNF and NGF in animal research models.
Semax BDNF and NGF Research: Neurotrophic Factor Studies
Semax · Published April 9, 2026 · Updated May 18, 2026 · 8 min read
Quick Answer
Semax BDNF and NGF research examines neurotrophic factor expression, TrkB and TrkA signaling, and brain region specificity in rodent models. Studies measure BDNF/NGF mRNA and protein levels, downstream TrkB/TrkA signaling, and hippocampal and cortical expression patterns. For research use only, not for human consumption.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
Frequently Asked Questions
What is Semax in research contexts?
+
Semax is a synthetic heptapeptide derived from the ACTH(4-10) fragment with extended stability via a C-terminal Pro-Gly-Pro tail. It is studied in preclinical models for cognitive endpoints, BDNF and NGF expression, and neuroprotection in cerebral ischemia.
How does Semax affect BDNF and NGF expression?
+
Semax administration in rodent models elevates BDNF and NGF mRNA and protein in hippocampus, cortex, and other brain regions, with downstream activation of TrkB and TrkA signaling. The neurotrophic effects link to Semax's cognitive and neuroprotective phenotype.
What neurotrophic endpoints define Semax research?
+
Endpoints include brain region BDNF and NGF expression (qPCR, ELISA, Western blot), TrkB and TrkA phosphorylation, downstream signaling (CREB, mTOR, MAPK), and integrated assessment of how neurotrophic effects link to cognitive and neuroprotective outcomes.
Is Semax approved for human use?
+
No. Semax is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.
Glossary
Key terms used in this article.
- ACTH(4-10)
- The 4-10 amino acid fragment of adrenocorticotropic hormone, the natural sequence from which Semax is derived.
- BDNF
- Brain-derived neurotrophic factor, a key neurotrophin supporting neuronal survival, synaptic plasticity, and learning.
- NGF
- Nerve growth factor, the prototypical neurotrophin essential for peripheral and central neuronal survival and growth.
- Intranasal Delivery
- Administration through the nasal mucosa, used for peptides like Semax to bypass first-pass metabolism and access the CNS.
- Heptapeptide
- A peptide consisting of seven amino acid residues; Semax has the sequence Met-Glu-His-Phe-Pro-Gly-Pro.
More from the Blog
Continue exploring research insights and updates.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
